Scribe Therapeutics has secured clearance from th
Author: Michael
Cognition Therapeutics completed a planned meetin
BioCardia presented preliminary open-label result
Commercial multi-modal screening pathways launch
The AI-powered nutrition clinic is betting that
New research from Beacon Biosignals explores how
New global report suggests the sector’s next c
HAYA Therapeutics announced that the first cohort
Eisai outlined new and expanded clinical data for
Capsida Biotherapeutics has closed its synrgy Pha